
Navneet Puri, PhD
Advertisement
Articles by Navneet Puri, PhD




A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.
Advertisement
Latest Updated Articles
First Vyluma product tackles pediatric myopiaJuly 23rd 2021
Nevakar spins off ophthalmic-only company VylumaJune 1st 2021
Vyluma pipeline focuses on refractive errorJuly 22nd 2021
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
High Point University optometry school earns ACOE preliminary approval
2
Tenpoint Therapeutics submits NDS for Yuvezzi presbyopia drop to Health Canada
3
Takeaways from this week in optometry: November 16-20
4
Polygenic risk flags patients likely to need more glaucoma treatment
5
